Detalhe da pesquisa
1.
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions.
Cancer
; 130(1): 41-50, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658645
2.
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
Cancer
; 130(8): 1270-1280, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153814
3.
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets.
Brief Bioinform
; 23(1)2022 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607353
4.
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey.
Ann Hematol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630129
5.
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
Cancer
; 129(11): 1704-1713, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932983
6.
Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor.
Am J Transplant
; 23(9): 1446-1450, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061187
7.
Immunological profile in a pediatric population of patients with spherocytosis. A single-center experience.
Blood Cells Mol Dis
; 98: 102700, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055084
8.
Management of polycythemia vera: A survey of treatment patterns in Italy.
Eur J Haematol
; 110(2): 161-167, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36319575
9.
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review.
Acta Haematol
; 146(4): 331-337, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068478
10.
Impact of restrictive measures due to the Covid-19 pandemic on the incidence of immune thrombocytopenia in children: an Italian single center experience.
Pediatr Hematol Oncol
; 40(2): 192-195, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35786388
11.
In silico design of recombinant multi-epitope vaccine against influenza A virus.
BMC Bioinformatics
; 22(Suppl 14): 617, 2022 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35109785
12.
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models.
BMC Bioinformatics
; 22(Suppl 14): 626, 2022 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35590242
13.
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis.
Cancer
; 128(13): 2449-2454, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363892
14.
Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells.
Br J Haematol
; 197(1): 110-119, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34961933
15.
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study.
Br J Haematol
; 197(2): 190-200, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137397
16.
Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients.
J Clin Immunol
; 42(1): 130-145, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664192
17.
IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis.
Int J Mol Sci
; 23(8)2022 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35457175
18.
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
Cancer
; 127(15): 2657-2665, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794557
19.
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
Br J Haematol
; 193(2): 356-368, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222197
20.
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.
Hematol Oncol
; 39(3): 409-418, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590502